CompanyTrack
E

ESP DIAGNOSTICS LIMITED

Active Newcastle Upon Tyne

Agents specialized in the sale of other particular products

2 employees Website
Life sciences and medical technology Agents specialized in the sale of other particular productsResearch and experimental development on biotechnology +1
E

ESP DIAGNOSTICS LIMITED

Agents specialized in the sale of other particular products

Founded 31 May 2021 Active Newcastle Upon Tyne, England 2 employees espdiagnostics.com
Life sciences and medical technology Agents specialized in the sale of other particular productsResearch and experimental development on biotechnologyOther professional, scientific and technical activities n.e.c.
Accounts Submitted 28 Feb 2025
Confirmation Statement Submitted 18 Jun 2025
Net assets £16.20K £35.48K 2024 year on year
Total assets £95.67K £6.25K 2024 year on year
Total Liabilities £72.45K £34.72K 2024 year on year
Charges None No charges registered

AI Analysis

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Registered Address

Sandgate House 102 Quayside Newcastle Upon Tyne Tyne And Wear NE1 3DX England

Office (Newcastle upon Tyne)

The Biosphere Draymans Way NE4 5BS United Kingdom

Credit Report

Discover ESP DIAGNOSTICS LIMITED's Credit Score, limit, and payment likelihood.

Mutual Companies

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2023–2024)

Cash in Bank

£64.83k

Increased by £39.85k (+160%)

Net Assets

£16.20k

Decreased by £35.48k (-69%)

Total Liabilities

£72.45k

Increased by £34.72k (+92%)

Turnover

N/A

Employees

2

Decreased by 2 (-50%)

Debt Ratio

76%

Increased by 34 (+81%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

£136k awarded
Show:

Investors (0)

No investor information available

Officers

Officers

1 active 3 resigned
Status
Marzena Kurzawa-akanbiDirectorPolish,britishUnited Kingdom428 Jul 2022Active

Shareholders

Shareholders (6)

Marzena Kurzawa-akanbi
45.0%
4519 Jun 2024
Newcastle University Holdings Limited
35.0%
3519 Jun 2024
Lina Patterson
0.0%
019 Jun 2024

Persons with Significant Control

Persons with Significant Control (2)

2 Active 1 Ceased

Marzena Kurzawa-akanbi

Polish

Active
Notified 8 Jul 2022
Residence United Kingdom
DOB March 1983
Nature of Control
  • Ownership Of Shares 25 To 50 Percent
  • Voting Rights 25 To 50 Percent

Newcastle University Holdings Limited

United Kingdom

Active
Notified 8 Jul 2022
Nature of Control
  • Ownership Of Shares 25 To 50 Percent
  • Voting Rights 25 To 50 Percent

Christopher Miles Morris

Ceased 8 Jul 2022

Ceased

Group Structure

Group Structure

ESP DIAGNOSTICS LIMITED Current Company

Charges

Charges

No charges registered

Documents

Company Filings

DateCategoryDescriptionDocument
19 Jun 2025OfficersChange to director Dr Marzena Kurzawa-Akanbi on 2025-06-18View(2 pages)
18 Jun 2025Confirmation StatementConfirmation statement made on 2025-06-18 with updatesView(3 pages)
20 Mar 2025OfficersTermination of Dale Athey as director on 2025-03-13View(1 page)
28 Feb 2025AccountsAnnual accounts made up to 2024-05-31View(11 pages)
14 Jan 2025OfficersTermination of Louis Lamontagne as director on 2024-10-25View(1 page)
19 Jun 2025 Officers

Change to director Dr Marzena Kurzawa-Akanbi on 2025-06-18

18 Jun 2025 Confirmation Statement

Confirmation statement made on 2025-06-18 with updates

20 Mar 2025 Officers

Termination of Dale Athey as director on 2025-03-13

28 Feb 2025 Accounts

Annual accounts made up to 2024-05-31

14 Jan 2025 Officers

Termination of Louis Lamontagne as director on 2024-10-25

Recent Activity

Latest Activity

Change to director Dr Marzena Kurzawa-Akanbi on 2025-06-18

8 months ago on 19 Jun 2025

Confirmation statement made on 2025-06-18 with updates

8 months ago on 18 Jun 2025

Termination of Dale Athey as director on 2025-03-13

11 months ago on 20 Mar 2025

Annual accounts made up to 2024-05-31

11 months ago on 28 Feb 2025

Termination of Louis Lamontagne as director on 2024-10-25

1 years ago on 14 Jan 2025